Clinical characteristics of treatment-seeking prescription opioid vs. heroin-using adolescents with opioid use disorder
- PMID: 19081205
- PMCID: PMC2746065
- DOI: 10.1016/j.drugalcdep.2008.10.015
Clinical characteristics of treatment-seeking prescription opioid vs. heroin-using adolescents with opioid use disorder
Abstract
Objectives: To compare the clinical characteristics of treatment-seeking prescription opioid-using adolescents with DSM-IV opioid use disorder (OUD) to those with heroin-using OUD adolescents.
Method: We analyzed the data on OUD adolescents (94, ages 14-18 years) extracted from the parent study dataset comparing clinical characteristics of treatment-seeking OUD to non-OUD adolescents from a adolescent substance abuse treatment program in Baltimore, MD. The sample consisted of 41 non-heroin prescription opioid-using and 53 heroin-using OUD adolescents who were assessed cross-sectionally using standardized interviews and self-reports. Chi-square and t-tests were performed to determine group differences on demographic, substance use, psychiatric and HIV-risk behaviors.
Results: Both groups were older (mean 17 years), predominantly Caucasian, and had a suburban residence; they had high rates of co-occurring psychiatric disorders (83%) and they reported moderately high depression symptoms. The heroin-using sample was more likely to have dropped out of school, be dependent on opioids and inject drugs using needles. The prescription opioid-using OUD youth were more likely to meet criteria for multiple SUDs (including prescription sedatives and psychostimulants), current ADHD and report selling drugs; and more likely to be court ordered to current treatment and report prior psychiatric treatment.
Conclusions: Both groups of treatment-seeking OUD adolescents had multiple comorbidities but there were substantial differences between prescription opioid-users and heroin-users. These differences may suggest different prognoses and treatment implications. Future research may shed light on the factors leading to differences in choice of opioids and their impact on treatment outcomes; and assess the role of agonist assisted treatments and integrated psychiatric care.
Figures
References
-
- Brands B, Blake J, Sproule B, Gourlay D, Busto U. Prescription opioid abuse in patients presenting for methadone maintenance treatment. Drug Alcohol Depend. 2004;73:199–207. - PubMed
-
- Center for Disease Control and Prevention. Viral Hepatitis and injection drug users. Fact Sheet Series. Author; Atlanta, GA: 2002. [September 15, 2007]. http://www.cdc.gov/IDU/hepatitis/viral_hep_drug_use.htm.
-
- Center for Disease Control and Prevention. Author; Atlanta, GA: 2007. [September 19, 2007]. HIV prevention among injection drug users. http://www.cdc.gov/IDU/default.htm. 2007.
-
- Ciraulo DA, Piechniczek-Buczek J, Iscan EN. Outcome predictors in substance use disorders. Psychiatr Clin North Am. 2003;26:381–409. - PubMed
-
- Clemmey P, Payne L, Fishman M. Clinical characteristics and treatment outcomes of adolescent heroin users. J Psychoactive Drugs. 2004;36:85–94. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
